Henry Schein Inc
XMUN:HS2
Relative Value
The Relative Value of one
HS2
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 61.86 EUR,
Henry Schein Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
HS2 Competitors Multiples
Henry Schein Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Henry Schein Inc
XMUN:HS2
|
9.2B EUR | 0.7 | 23.6 | 11.3 | 15.8 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
120.3B USD | 0.3 | 29.6 | 20.8 | 23.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.3B USD | 0.2 | 45.3 | 15.3 | 19.6 | |
| US |
|
Cencora Inc
NYSE:COR
|
68.5B USD | 0.2 | 44.1 | 14.9 | 19.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.6B USD | 0.2 | 34.1 | 16.6 | 21.8 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
35.7B AUD | 6 | 68 | 51.2 | 51.2 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.9B CNY | 1.5 | 17.3 | 13.4 | 13.4 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.4B HKD | 0.1 | 8.6 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
7.1B USD | 0.8 | 47.6 | 27.4 | 27.4 |